CHF144.60
0.70% today
SIX Swiss Exchange, Aug 29, 01:46 pm CET
ISIN
CH0468525222
Symbol
MOVE

Medacta Stock price

CHF143.60
+3.40 2.43% 1M
+12.40 9.45% 6M
+37.00 34.71% YTD
+13.20 10.12% 1Y
+55.40 62.81% 3Y
+56.60 65.06% 5Y
+47.50 49.43% 10Y
+47.50 49.43% 20Y
SIX Swiss Exchange, Closing price Thu, Aug 28 2025
-1.60 1.10%
ISIN
CH0468525222
Symbol
MOVE

Key metrics

Basic
Market capitalization
CHF2.9b
Enterprise Value
CHF3.1b
Net debt
CHF194.3m
Cash
CHF34.0m
Shares outstanding
19.9m
Valuation (TTM | estimate)
P/E
42.0 | 35.2
P/S
5.3 | 4.5
EV/Sales
5.6 | 4.8
EV/FCF
1,346.9
P/B
8.2
Dividends
DPS
CHF0.69
Yield 1Y | 5Y
0.5% | 0.4%
Growth 1Y | 5Y
25.5% | -
Payout 1Y | 3Y
20.2% | 22.8%
Increased
4 Years
Financials (TTM | estimate)
Revenue
CHF552.9m | CHF648.5m
EBITDA
CHF150.2m | CHF175.1m
EBIT
CHF88.6m | CHF102.9m
Net Income
CHF68.2m | CHF81.3m
Free Cash Flow
CHF2.3m
Growth (TTM | estimate)
Revenue
15.6% | 17.3%
EBITDA
19.2% | 64.1%
EBIT
24.2% | 16.5%
Net Income
53.9% | 19.2%
Free Cash Flow
134.6%
Margin (TTM | estimate)
Gross
67.6%
EBITDA
27.2% | 27.0%
EBIT
16.0%
Net
12.3% | 12.5%
Free Cash Flow
0.4%
Financial Health
Equity Ratio
47.9%
Return on Equity
19.2%
ROCE
14.9%
ROIC
11.2%
Debt/Equity
0.6
More
EPS
CHF3.4
FCF per Share
CHF0.1
Short interest
-
Employees
2k
Rev per Employee
CHF290.0k
Show more

Is Medacta a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Medacta Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Medacta forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a Medacta forecast:

Buy
92%
Hold
8%

Financial data from Medacta

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
553 553
16% 16%
100%
- Direct Costs 179 179
17% 17%
32%
374 374
15% 15%
68%
- Selling and Administrative Expenses 267 267
13% 13%
48%
- Research and Development Expense 19 19
3% 3%
3%
150 150
19% 19%
27%
- Depreciation and Amortization 62 62
13% 13%
11%
EBIT (Operating Income) EBIT 89 89
24% 24%
16%
Net Profit 68 68
54% 54%
12%

In millions CHF.

Don't miss a Thing! We will send you all news about Medacta directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medacta Stock News

AD HOC NEWS
4 months ago
Medacta Group SA / CH0468525222
AD HOC NEWS
5 months ago
Medacta Group SA / CH0468525222

Company Profile

Medacta Group SA engages in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. The firm offers personalized kinematic models and three-dimensional planning tools for use in hip, knee, shoulder, and spine procedures. It operates through the following geographical segments: Europe, North America, Asia Pacific, and Rest of the World. The company was founded by Alberto Siccardi in 1999 and is headquartered in Castel San Pietro, Switzerland.

Head office Switzerland
CEO Francesco Siccardi
Employees 1,907
Founded 1999
Website www.medacta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today